PubRank

Jeffrey Eastham-Anderson

Author PubWeight™ 40.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2006 13.75
2 Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2009 4.12
3 B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010 2.17
4 Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors. PLoS One 2009 2.07
5 PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell 2010 1.75
6 Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab. Clin Cancer Res 2009 1.70
7 DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. Proc Natl Acad Sci U S A 2013 1.53
8 PPM1H is a p27 phosphatase implicated in trastuzumab resistance. Cancer Discov 2011 1.50
9 FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways. PLoS One 2011 1.35
10 Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol 2013 1.24
11 Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models. J Pathol 2012 1.15
12 Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med 2009 1.14
13 MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length. Proc Natl Acad Sci U S A 2012 0.99
14 Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes. PLoS One 2012 0.98
15 Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Clin Cancer Res 2008 0.97
16 Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response. Neoplasia 2013 0.87
17 Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy. J Clin Invest 2013 0.84
18 EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS. PLoS One 2013 0.82
19 CRIg mediates early Kupffer cell responses to adenovirus. J Leukoc Biol 2012 0.81
20 Residual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity. PLoS One 2012 0.78
21 Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis. Neoplasia 2013 0.78
22 Impaired FcεRI stability, signaling, and effector functions in murine mast cells lacking glycosylphosphatidylinositol-anchored proteins. Blood 2011 0.75